Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GeNO Nitrosyl System in PAH
NCT01092559Phase 2Completed
- Sponsor
- Genomatica
- Start
- Oct 2010
- Primary completion
- Jul 2011
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in pulmonary arterial hypertension (PAH), sponsored by Genomatica. Started Oct 2010; status: completed.
02
Drugs
nitric oxide
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01092559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092559.